Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - DEPRECIATION & AMORTIZATION
Depreciation & Amortization AKBA - Akebia Therapeutics, Inc.
41.8 M
LAST VALUE
4.98%
2 YEAR CAGR
76.82%
5 YEAR CAGR
182.73%
10 YEAR CAGR